These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28685501)

  • 1. Pazopanib for second recurrence of osteosarcoma in pediatric patients.
    Umeda K; Kato I; Saida S; Okamoto T; Adachi S
    Pediatr Int; 2017 Aug; 59(8):937-938. PubMed ID: 28685501
    [No Abstract]   [Full Text] [Related]  

  • 2. Pazopanib in metastatic osteosarcoma: significant clinical response in three consecutive patients.
    Safwat A; Boysen A; Lücke A; Rossen P
    Acta Oncol; 2014 Oct; 53(10):1451-4. PubMed ID: 25143189
    [No Abstract]   [Full Text] [Related]  

  • 3. Pazopanib in relapsed osteosarcoma patients: report on 15 cases.
    Longhi A; Paioli A; Palmerini E; Cesari M; Abate ME; Setola E; Spinnato P; Donati D; Hompland I; Boye K
    Acta Oncol; 2019 Jan; 58(1):124-128. PubMed ID: 30207179
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete pathologic response in soft tissue sarcoma lung metastases with pazopanib.
    Eroglu Z; Kim J; Wilczynski S; Chow WA
    J Thorac Oncol; 2014 Jan; 9(1):e4-6. PubMed ID: 24346105
    [No Abstract]   [Full Text] [Related]  

  • 5. An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model.
    Oshiro H; Tome Y; Miyake K; Higuchi T; Sugisawa N; Kanaya F; Nishida K; Hoffman RM
    Sci Rep; 2021 Apr; 11(1):8583. PubMed ID: 33883561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib.
    Mori Y; Kinoshita S; Kanamori T; Kataoka H; Joh T; Iida S; Takemoto M; Kondo M; Kuroda J; Komatsu H
    Intern Med; 2018 Sep; 57(18):2753-2757. PubMed ID: 29780156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.
    Palma N; Morris JC; Ali SM; Ross JS; Pal SK
    Eur Urol; 2015 Jul; 68(1):168-70. PubMed ID: 25766722
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of pazopanib for local and lung metastases in Stewart-Treves syndrome.
    Hayashi M; Makino T; Mori N; Mizawa M; Shimizu T
    Eur J Dermatol; 2020 Feb; 30(1):68-69. PubMed ID: 32250262
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of refractory Ewing sarcoma to pazopanib.
    Alcindor T
    Acta Oncol; 2015 Jul; 54(7):1063-4. PubMed ID: 25345493
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group.
    Koinis F; Agelaki S; Karavassilis V; Kentepozidis N; Samantas E; Peroukidis S; Katsaounis P; Hartabilas E; Varthalitis II; Messaritakis I; Fountzilas G; Georgoulias V; Kotsakis A
    Br J Cancer; 2017 Jun; 117(1):8-14. PubMed ID: 28510571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study
    Gelderblom H; Judson IR; Benson C; Merimsky O; Grignani G; Katz D; Freivogel KW; Stein D; Jobanputra M; Mungul A; Manson SC; Sanfilippo R
    Acta Oncol; 2017 Dec; 56(12):1769-1775. PubMed ID: 28723233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to pazopanib in two pediatric patients with pretreated relapsing synovial sarcoma.
    Casanova M; Basso E; Magni C; Bergamaschi L; Chiaravalli S; Carta R; Tirtei E; Massimino M; Fagioli F; Ferrari A
    Tumori; 2017 Jan; 103(1):e1-e3. PubMed ID: 27647230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term response to pazopanib in an elderly man with mRCC. A case report.
    D'Aniello C; Cavaliere C; Pisconti S; Facchini G
    Tumori; 2014; 100(6):e305-8. PubMed ID: 25688517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pazopanib: an antiangiogenic drug in perspective.
    Castaneda CA; Gomez HL
    Future Oncol; 2009 Nov; 5(9):1335-48. PubMed ID: 19903063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of pulmonary metastases from osteosarcoma in pediatric and adolescent patients.
    Steliga M; Vaporciyan A
    Cancer Treat Res; 2009; 152():185-201. PubMed ID: 20213391
    [No Abstract]   [Full Text] [Related]  

  • 16. Bronchopleural fistula arising after commencement of pazopanib for progressive sarcoma.
    Cohen L; Neuhaus S; Chryssidis S; Kotasek D
    ANZ J Surg; 2017 Jul; 87(7-8):E48-E49. PubMed ID: 25556827
    [No Abstract]   [Full Text] [Related]  

  • 17. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.
    Briccoli A; Rocca M; Salone M; Guzzardella GA; Balladelli A; Bacci G
    Surg Oncol; 2010 Dec; 19(4):193-9. PubMed ID: 19515554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pazopanib for the treatment of breast cancer.
    Amiri-Kordestani L; Tan AR; Swain SM
    Expert Opin Investig Drugs; 2012 Feb; 21(2):217-25. PubMed ID: 22233389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Pazopanib in Patients With Relapsed Osteosarcoma.
    Elete KR; Albritton KH; Akers LJ; Basha R; Ray A
    J Pediatr Hematol Oncol; 2020 May; 42(4):e254-e257. PubMed ID: 30531600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pazopanib for treatment of renal cell carcinoma and soft tissue sarcomas].
    Brotelle T; Bay JO
    Bull Cancer; 2014 Jun; 101(6):641-6. PubMed ID: 24977453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.